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Background: The purpose of the study was to understand the function and expression of ATF2 by JNK and p38
signal pathways in the chondrocytes apoptosis of articular cartilage of the Kashin-Beck disease (KBD).
Methods: The changes of ATF2, JNK and p38 mRNAs and proteins were investigated between cartilage and
chondrocyte as well as KBD and normal. JNK and p38 inhibitors were used as treatments to prevent apoptosis in
chondrocytes from KBD patients.
Results: It was found that the protein levels of p-p38, p-JNK, ATF2 and p-ATF2 increased in KBD human cartilage
which is in line with the higher mRNA levels of p38, JNK and ATF2 as compared both with normal cartilage and
KBD chondrocytes. In addition, p-ATF2 was only detected in KBD cartilage. Furthermore, JNK inhibitor was more
effective than p38 inhibitor in preventing chondrocyte apoptosis at equal concentrations of 10 μM.
Conclusion: These findings indicated the expression of p-ATF2 by JNK and p38 signal pathways involved in the
chondrocyte apoptosis in cartilage with KBD.
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Kashin-Beck disease (KBD) is a chronic, endemic osteo-
arthropathy which occurs mainly in regions from the
northeast China to Sichuan-Tibet Plateau, Russia and
North Korea [1]. Approximately 0.7 million patients in
China suffer from the disease, and the 105 million resi-
dents who are living in the above-mentioned provinces
are at risk [2-4]. Three major environmental etiologies
have been suggested: endemic selenium deficiency, cereal
contamination by mycotoxin-producing fungi, and high
humic acid levels in drinking water [5-11].
The KBD manifests cartilage specific pathological
changes and chondrocytes apoptosis in vivo. It affects
mainly the developing hyaline cartilage, causing apop-
tosis and necrosis of chondrocytes in the epiphyseal,* Correspondence: guox@mail.xjtu.edu.cn
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reproduction in any medium, provided the orgrowth plate and articular cartilage. Clinically, this dis-
ease manifests as enlarged interphalangeal joints, short-
ened fingers, deformed and enlarged joints, and limited
motion of joints in the extremities. These result in
stunted development of cartilage and bone, and finally
secondary osteoarthropathy [12-14]. KBD patients were
diagnosed by “Diagnosis criterion of Kashin–Beck dis-
ease” in China (WS/ T207—2010) [15]. For adults with
KBD, the deformed joints, especially in the weight-bear-
ing joints, keep them away from work and affect their
normal lives. The current treatment for KBD patients with
serious pathological characteristics (grade II/III) is to do
surgery on the abnormal articular cartilage. Meanwhile,
investigation of the pathology of KBD as well as the
effective prevention and therapy methods are a work in
progress.
c-Jun N-terminal kinase (JNK) and p38 protein kinase
pathways are two major pathways of mitogen-activated
protein kinase (MAPK) signal transduction [16], which
play important roles in the stimulation of apoptotic. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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KBD is a particular type of osteoarthropathy, manifested
by chondrocyte apoptosis and pathological changes after
cartilage necrosis. Inflammation may be both a primary
event in KBD and/or a secondary event in the disease
for the observed biochemical changes with the cartilage,
such as the higher expression of TNF-α, VEGF, TGF-β
and IL-1 [20,21].
Our previous study comparing gene expression levels
between KBD and normal articular cartilage tissue re-
vealed a number of up-regulated genes related to apop-
tosis, e.g. TNFAIP6, TNFRSF11B, BCL-2, BAX and
others [20]. A reanalysis of this data pointed out also
p38 (NM_001315), JNK (NM_002750) and ATF2
(NM_001880) were up-regulated more than two-fold in
KBD patients as compared to normal donors (p-value<0.01).
Therefore, we hypothesized that JNK and p38 signaling
pathways may be related to the cartilage degeneration in
KBD patients.
In our work, the mRNA and protein levels of p38, JNK
and ATF2 were studied between cartilage and chondro-
cyte as well as KBD and normal. Meanwhile, the effects
of JNK and p38 inhibitors on the culture of KBD
chondrocytes were determined to understand their func-
tion in the chondrocytes apoptosis of KBD.
Methods
Sampling of human articular cartilage
Specimens of human articular cartilage were collected
from a total of 15 KBD patients (9 males and 6 females,
44-58 years of age) who were diagnosed as the second orFigure 1 Characteristics of KBD pateients. A. Representative patient wit
of the two knees. B and C. Radiographic images of the left knee of a patie
and (C) lateral directions, showing an enlarged joint space and obvious joi
articular cartilage (50 y, male), and E Hematoxylin-eosin staining of KBD art
necrotic chondrocytes and fibrous cartilage in the middle and deep layer othird degree of KBD, based on the Diagnosing Criteria to
Kashin-Beck disease in China [15,22]. The donors were
inhabitants of endemic regions of Linyou, Yongshou, and
Qianyang in Shaanxi Province of China. Normal human
knee cartilage samples were collected from donors (4
males and 2 females, 38-55 years-of age) who were suffer-
ing from traffic accidents and undergoing total knee re-
placement surgery from non-KBD areas. The health status
of control cartilage samples was examined through histo-
logical examination of hematoxylin-eosin stained sections
to exclude osteoarthritis (OA), rheumatoid arthritis (RA)
and other bone and cartilage diseases. Permission for this
study was given by the Human Ethics Committee of the
Xi’an Jiaotong University. All patients and normal donors
provided a written informed consent for participation in
the study and publication their individual clinical details
and clinical images.
Cartilage tissues of every KBD donor were divided into
two parts, so that one part was used to extract mRNAs
and proteins, while the other part was used for cell cul-
ture. One representative patient with grade III KBD, the
radiographic images of the left knee of a patient with
grade II KBD and HE staining pictures of articular cartil-
age from normal and KBD are shown in Figure 1. Mean-
while, proteins extracted from every normal donor were
kept separately and the rest cartilage tissues of normal
donors were used for cell culture.
Cultivation of human articular chondrocytes
Within 8 h after surgery, the cartilage tissue was col-
lected and washed with phosphate-buffered saline (PBS)h grade III KBD (male patient, age 55 years), showing retarded growth
nt with grade II KBD (male patient, age 48 years), (B) anteroposterior
nt space narrowing. D Hematoxylin-eosin staining of adult control
icular cartilage with chondrocyte clusters in the eroded surface,
f knee joint (55 y, male). (D and E, 40 ×).
Table 1 The primers used for the real-time reverse
transcription PCR
Gene Forward primer Reverse primer
JNK
(NM_002750) 5’- CAA GCA CCT TCA
TTC TGC TG-3’
5’- GCC AGA CCG AAG TCA
AGA AT-3’
p38
(NM_001315) 5’- CGA GCG TTA CCA
GAA CCT GT-3’
5’- TGG AGA GCT TCT TCA
CTG CC -3’
ATF2
(NM_001880) 5’- GGT GCT TTG TAA
ACA CGG CT -3’
5’- GCA GTC CTT TCT CAA
GTT TCC -3’
GAPDH 5’- GAA GGT GAA GGT
CGG AGT C-3’
5’- GAA GAT GGT GAT GGG
ATT TC-3’
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which were incubated at 37°C with trypsin for 10 min.
After removing the trypsin solution, the cartilage was
digested at 37°C with type II collagenase using 1 ml of
digestion solution per 100 mg tissue (Gibco, Grand
Island, NY, USA). Every 3 hours, the digested fluid was
collected through gauze to remove undigested cartilage
fragments, then we collected the chondrocytes by centri-
fugation and reused the collagenase solution to digest
the cartilage pieces. This protocol was repeated up to
three times until we got enough chondrocytes for further
experiments. Chondrocytes from individual donors were
kept strictly separated in all experiments. Cells were
plated in cell culture flasks in DMEM/F12 (1:1) (HyClone,
Thermo Scientific, Logan, UT, USA), supplemented
with 10% fetal bovine serum (FBS), 100 U/ml of peni-
cillin, and 100 μg/ml of streptomycin, and maintained
in a humidified atmosphere at 5% CO2 and 37°C. The
medium was renewed two or three times a week
according to the cell growth state. Primary cells were
used in all experiments.
RNA extraction and real-time quantitive PCR
Total RNAs were extracted using RNAfast200 kit
(Fastagen, Shanghai, China), whose quality and concen-
tration were assayed by a NanoDrop spectrophotometer
(Thermo Scientific, USA), and then subjected to reverse
transcription using RevertAidTM First Strand cDNA
Synthesis kit (Fermentas, MBI, Vilnius, Lithuania) by
Eppendorf gradient type mastercycler (Eppendorf,
Hamburg, Germany). Reverse transcription products
were used for quantitative real-time PCR analysis
performed with iQTM5 Real-Time PCR Detection Sys-
tems device (Bio-Rad, Philadelphia, PA, USA) using
BioEasy SYBR Green I Real Time PCR Kit (Bioer,
Hangzhou, China) with oligonucleotide pairs specific for
human JNK, p38, ATF2 and GAPDH with the following
cycling conditions: 94°C for 2 mins, 94°C for 10 s, 58°C
for 30 s, and 72°C for 30 s for 40 cycles, followed by a
melting curve analysis. The forward and reverse primer
pairs designed to generate a 102-bp fragment of JNK, a
107-bp fragment of p38, a 104-bp fragment of ATF2,
and a 226-bp fragment of GAPDH (an internal control)
are presented in Table 1. The results of relative gene ex-
pression data were analyzed using Real-Time quantita-
tive PCR and the 2-ΔΔCT method [23].
Western blot analysis
The proteins from cartilage and chondrocytes of KBD pa-
tients and from normal human cartilage were extracted
with RIPA Cell Lysis Solution (Beyotime, Jiangsu, China),
which was supplemented with PMSF and PhosSTOP
alkaline phosphatase inhibitors (Hoffmann-La Roche Ltd,
Basel, Switzerland). Protein concentration was assayed toadjust an equivalent loading dose of 50 μg. Before electro-
phoresis, all the samples were boiled in sodium dodecy-
lsulfate (SDS) sample buffer for 5 mins. The lysates were
separated by polyacrylamide gel electrophoresis and trans-
ferred to a nitrocellulose membrane (Bio-Rad, Hercules,
CA, USA). The membrane was then incubated at room
temperature in a blocking solution composed of 5%
skimmed milk powder dissolved in Tris-buffered saline
(TBS), pH 7.4, containing 0.1% Tween-20 for 1 h, followed
by incubation in the blocking solution with anti-human
JNK, p-JNK, p38, p-p38, ATF2, p-ATF2 antibodies separ-
ately at 4°C overnight. All the antibodies were purchased
from Bioworld Technology (St. Louis Park, MN, USA; Cat
No: BS3631, BS4763, BS3567, BS4766, BS1021, BS4018).
The membrane was washed three times in TBS-Tween
(5 mins each), and then incubated with an HRP-conjugated
IgG antibody in the blocking solution. After washed three
times in TBS-Tween and once in TBS (5 mins each), the
immunoreactive protein was visualized using an enhanced
chemiluminescence detection kit (ECL, Thermo Scientific,
USA). To show equal loading of the protein samples,
β-actin was used as internal control.
The effects of JNK and p38 inhibitors on the culture of
KBD chondrocytes
In order to understand if JNK and p38 activated in the
apoptosis of KBD chondrocytes, we seeded primary KBD
chondrocytes on 6-well dishes and divided into 3 groups:
1) control group, 2) p38 inhibitor (SB203580) group, 3)
JNK inhibitor (SP600125) group. The effective inhibition
doses of SB203580 for p38 and SP600125 for JNK pro-
tein with 10 μM and 20 μM were tested with KBD
chondrocytes.
For control groups we follow the above mentioned
chondrocytes culture protocol, while for JNK and p38
inhibitors groups, the culture medium was added with
SB203580 and SP600125 individually before used for cell
cultures. One week later, early chondrocyte apoptosis
Figure 2 qPCR of ATF2, JNK and p38 in cartilage compared
with chondrocytes both from KBD. The expression levels of p38,
JNK and ATF2 mRNAs were about 1.3-fold, 3.2-fold and 2.7-fold
higher in cartilage than in chondrocytes samples. * p < 0.05
Han et al. BMC Musculoskeletal Disorders 2013, 14:209 Page 4 of 10
http://www.biomedcentral.com/1471-2474/14/209rates of the 3 groups were determined by a flow cytometer
(Becton Dickinson, Mountain View, CA, USA) using
AnnexinV-FITC Apoptosis Detection kit according to the
manufacturers’ instructions (KenGEN, Nanjing, China).
Moreover, apoptotic morphological changes in the nuclear
chromatin were detected by DAPI stain. Chondrocytes
were washed with PBS and incubation with DAPI stain so-
lution for 10 min (Beyotime, Haimen, China). Then the
chondrocytes were viewed under a fluorescence micro-
scope (Olympus, IX-70, Japan) within 2 h. Furthermore,
real-time quantitative PCR and western blot analyses were
used to compare mRNA (NM_002750, NM_001315,
NM_001880) and protein (p-JNK, p-p38, ATF2, p-ATF2)
levels among the groups.
Statistical analysis
Every sample was studied in triplicate. Data are presented
as mean ± SD. Comparisons between the groups were car-
ried out using the Student’s two-tailed t-test. P-values less
than or equal to 0.05 were considered significant.
Results
Changes of p38, JNK and ATF2 mRNAs between KBD
cartilage and chondrocyte cultures
Gene expression profiles may vary according to cell cul-
ture conditions. Therefore, we performed a quantitative
RT-PCR analysis to compare the levels of ATF2, JNK
and p38 in KBD cartilage and those in cultured KBD
chondrocytes from the same donors. To our surprise, it
could be observed that the expression levels of JNK and
ATF2 mRNAs were about 3.2-fold (p < 0.01) and 2.7-fold
(p < 0.05) higher in cartilage samples than in chondrocytes,
while p38 levels remained stable with 1.3-fold in cartilage
compare with chondrocytes (Figure 2).
Changes of p-p38/p38, p-JNK/JNK and p-ATF2/ATF2
proteins
In order to find out whether the observed changes in
mRNA levels were reflected at the protein levels, west-
ern blot analysis was performed. The protein levels of
p38, p-p38 and JNK were detected with a significant in-
crease in KBD cartilage compared with KBD chondrocytes
(p < 0.05, and were 0.025, 0.040 and 0.032 respectively).
Interestingly, the p-JNK, ATF2 and p-ATF2 could only be
detected in KBD cartilage samples; the decrease in JNK
and ATF2 total protein levels in cultured chondrocytes
was in line with the lower level of their mRNA expression
respectively (Figure 3A).
The presence of p-p38, p-JNK, ATF2 and p-ATF2 in normal
and KBD cartilage
Whether the expression of p-p38, p-JNK, ATF2, and
p-ATF2 was specific to KBD was unknown, western blot
analysis of samples isolated from three normal donorsand three KBD patients was performed. It could be
observed that only the phosphorylated ATF2 could be
detected in the cartilage of KBD patients, while the ex-
pression of p-p38, p-JNK (p = 0.015) and ATF2 (p = 0.005)
increased dramatically in the KBD cartilage when com-
pared with that in normal cartilage (Figure 3B).
The presence of p-p38, p-JNK, ATF2 and p-ATF2 in normal
cartilage and chondrocyte cultures
Western blot analysis of cartilage and chondrocyte sam-
ples isolated from three normal donors was performed.
The level of p-p38 in normal cartilage was a bit higher
than that in normal chondrocytes. Meanwhile, the levels
of ATF2 (p = 0.059) and phosphorylated JNK (p = 0.032)
were detected in the cartilage samples other than in the
chondrocyte samples, and phosphorylated ATF2 was
absent in both cartilage and chondrocyte samples
(Figure 3C).
The effects of JNK and p38 inhibitors on the culture of
KBD chondrocytes
Figure 4 showed that 10 μM and 20 μM for each inhibi-
tor showed targeted phosphate protein blocked. There-
fore, lower dose with 10 μM was selected as the effective
inhibition dose of SB203580 for p38 and SP600125 for
JNK.
In control group, the early apoptosis rate was 7.2 ± 1.3%
(Figure 5A). The JNK inhibitors SP600125 decreased
apoptosis rate from 7.2 ± 1.3% to 3.4 ± 1.1% (p < 0.05),
while p38 inhibitor SB203580 had a less pronounced effect
on the percentage of apoptosis rate (5.8 ± 1.4%).
As shown in Figure 5B, DAPI-stained nuclei from
chondrocytes of control group showed cytoplasmic signs
Figure 3 Results of Western blotting analysis. A. Western blotting of p38, p-p38, JNK, p-JNK, ATF2 and p-ATF2 in cartilage and chondrocytes
both from KBD patient samples. p-JNK, ATF2 and p-ATF2 could not be detected in chondrocytes from KBD patients. B. Western blotting of p-p38,
p-JNK, ATF2 and p-ATF2 in normal and KBD cartilage samples. p-ATF2 could not be detected in normal cartilage. C. Western blotting of p-p38,
p-JNK, ATF2 and p-ATF2 in cartilage and chondrocytes both from normal samples. The levels of p-p38, p-JNK, ATF2 were higher in cartilage than
cultured chondrocytes and p-ATF2 was absent in cartilage and chondrocytes. * p < 0.05, * * p < 0.01.
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Figure 4 Western blotting results of inhibitors. A. Western blotting showed different doses of JNK inhibitor SP600125 on the expression of
p-JNK. B. Western blotting showed different doses of p38 inhibitor SB203580 on the expression of p-p38.
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tation and condensation were evident. In contrast, KBD
nuclei were bigger and rounder with inhibitors.
The expression levels of the p38, JNK and ATF2
mRNA were higher in the control group (Figure 5C).
The addition of SP600125 reduced the expression of JNK
and ATF2 mRNAs to less than 0.5-fold each (p < 0.05);
SB203580 decreased the level of p38 mRNAs to about
0.5-fold as well while had a less effect on the level of
ATF2 mRNA to 0.8-fold.
The p38 inhibitor SB203080 specifically prevented
phosphorylation of p38 (Figure 5D), while affected
slightly to p-JNK, ATF2 and p-ATF2; meanwhile, the
JNK inhibitor SP600125 efficiently blocked the phos-
phorylation of JNK and the total protein level of ATF2
as well as p-ATF2. SP600125 was not only a potent in-
hibitor of ATF2 phosphorylation; it also decreased the
protein amount of ATF2, which was in line with its
mRNA expression.
Discussion
The pathological mechanisms related to KBD are poorly
understood. One of the hallmarks of the disease is the
apoptosis of chondrocytes. Signaling pathways of JNK
and p38 have been associated with apoptotic events,
which could be linked to KBD. However during the cell
culture procedure, we had to wait for at least two weeks
until we could get enough chondrocytes, meanwhile only
the survival chondrocytes were examined, and thus we
might miss important information of certain mRNAs
and proteins in the two pathways. In this article, their
possible association with KBD is studied and demon-
strated by comparing mRNAs and proteins related to
these pathways between cartilage and chondrocyte as
well as KBD and normal, and the JNK and p38 inhibitors
were used to investigate their function in the KBD chon-
drocyte apoptosis.As shown, JNK and ATF2 mRNAs were higher ex-
pressed in KBD cartilage samples than normal samples
by reanalysis of previous data. While kept in cell culture
conditions, the KBD chondrocytes had their expression
declined significantly. Additionally, total proteins of
p-JNK, ATF2 and p-ATF2 were less expressed in normal
cartilage samples and after cell culture they were non-
detectable in KBD and normal chondrocytes. To conclu-
sion, p-ATF2 was not observed in normal cartilage, and
after cell culture, p-JNK, ATF2 and p-ATF2 were not
detected in all the chondrocytes samples from KBD and
normal, which indicated that p-ATF2 could only be
detected in KBD cartilage. The phenomena may refer to
the reason why the KBD chondrocyte could survive bet-
ter in cell culture medium other than the serum from
KBD patients. The previous studies have shown the in-
creased levels of TNF-α and IL-1β, abnormal expression
of Bax and Bcl-2 in the serum and synovial fluid of KBD
patients [24]. Moreover elevated levels of many apop-
totic markers [25] and NO level in serum [26] have been
shown in KBD, which may lead to the stimulated expres-
sion of p-ATF2, and if we use the serum from KBD pa-
tients to culture normal rabbit chondrocyte, it would
result in the pathological changes of normal chondrocytes
similar to KBD chondrocytes [27,28].
ATF2 is normally activated in response to signals that
converge on stress-activated protein kinases p38 and
JNK [29]. While during the study of KBD chondrocytes
cultured individually with p38 and JNK inhibitors, we
observed that the early apoptosis rates of KBD chon-
drocytes decreased by using both of them, and JNK in-
hibitor could better alleviate KBD apoptosis than p38
inhibitor (3.4 ± 1.1% vs 5.8 ± 1.4%), meanwhile JNK in-
hibitor showed ATF2 and p-ATF2 protein partially
blocked in KBD chondrocytes better than p38 inhibitor,
which was accordance with the decreased expression of
ATF2 mRNA level. The results suggested the expression
Figure 5 Analysis results of different treated groups. A. Apoptosis analysis of chondrocytes after different treatments for 3 days (control
cultures with early apoptosis rate of 7.2 ± 1.3%; for cultures supplemented with p38 inhibitor SB203580 the rate was 5.8 ± 1.4%; those
supplemented with JNK inhibitor SP600125 was 3.4 ± 1.1%). B. DAPI stain images of KBD chondrocytes in different groups (200 ×, control,
SB203580 and SP600125, control groups showed the nuclear fragmentation and condensation). C. qPCR of ATF2, JNK & p38 in chondrocytes of
different treatment normalized to GAPDH and normalized to control. SP600125 and SB203580 decreased the fold changes of ATF2 to 0.5 and 0.8
respectively, p < 0.001. D. Western blotting of p-p38, p-JNK, ATF2 and p-ATF2 in chondrocytes with different treatment. (The levels of p-p38,
p-JNK, ATF2 and p-ATF2 were lower in chondrocytes cultured with inhibitors, and p-ATF2 was more likely to be influenced by JNK inhibitor).
* p < 0.05, * * p < 0.01.
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through JNK signal pathway.
JNK and p38 MAPK pathways are activated by stress
and inflammatory signals with a variety of cell receptors,
including death receptors (FAS), inflammatory cytokine
receptors (TNF-a, TGF-b), G protein-coupled receptorsand antigen receptors [30-32]. Selenium deficiency in-
duced dysfunction of selenoproteins which exhibited a
variety of biological functions, including antioxidant
functions, maintaining cellular redox balance, and heavy
metal detoxification [33,34]; therefore compromise of
such important proteins would lead to oxidative stress
Han et al. BMC Musculoskeletal Disorders 2013, 14:209 Page 8 of 10
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oxygen species and compromise mitochondrial oxidative
phosphorylation, which lead to mitochondria-mediated
apoptosis [35,36]. In a rat model, T-2 toxin together
with selenium deficiency has been reported to cause
chondronecrosis development with similarities to KBD
[37]. Whether JNK and p38 pathways involved in the
chondrocytes apoptosis induced by T-2 toxin was under
way to clarify. Meanwhile, we will pay close attention
to selenium, especially the mechanism of the inhibition
effect of nano-selenium chondroitin sulfate [38] which
was prepared by our group on the T-2 toxin induced
apoptosis in the later experiments.
Based on the above, a supposed pathological process
for KBD (Figure 6) is as follows: A signal (inflammatory
factor or oxidative stress) arrives at the cell surface, acti-
vates the corresponding receptor that leads to the pro-
duction of a second messenger, such as cAMP or Ca2+,
which in turn activates JNK/p38 protein kinase. The
process could be described as: FasL, inflammatory cyto-
kines, oxidative stresses→ JNK/p38→ATF2, after which
ATF2 translocates to the cell nucleus, where it activates
and regulates the expression of selected genes. Finally,Figure 6 Supposed functional factors in JNK and p38 pathways relatethe activated JNK/p38 pathway induces chondrocyte
apoptosis. More details of possible functions of JNK/p38
signal pathway in KBD, and the comparison of KBD with
osteoarthritis, need to be examined in further studies.
In summary, obvious higher mRNA levels of JNK and
ATF2 as well as elevated expression levels of p-JNK,
p-ATF2 and ATF2 were observed in KBD cartilage. In
addition, JNK inhibitor was more effective than p38 in-
hibitor in the prevention of KBD chondrocyte apoptosis.
The current findings suggest the involvement of JNK
and p38 pathways correlated factors in the chondrocytes
apoptosis of KBD cartilage.
Conclusion
In conclusion, our studies have shown that the expres-
sion of p-ATF2 is important for the apoptosis of
chondrocytes in cartilage with KBD. The apoptotic func-
tion of ATF2 in KBD cartilage is mainly enhanced
through JNK signal pathway other than p38 signal path-
way. Thus, the activation of ATF2 through JNK pathway
may play an important role in chondrocyte apoptosis of
human KBD, which maybe a possible target in the pre-
vention and treatment of KBD.d to chondrocytes apoptosis of cartilage with KBD.
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